COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS

The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptabl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SHAH, Khalid, XU, Wei, SHAKYA, Sagar, WANG, Yong, DEMORIN, Frenel
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof. La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci.